Insight Molecular Diagnostics (IMDX) Tax Provisions (2020 - 2021)

Insight Molecular Diagnostics (IMDX) posted Tax Provisions of -$97000.0 for Q4 2021, up 94.59% sequentially from -$1.8 million in Q2 2021, and down 161.01% YoY from $159000.0 in Q4 2020.

Insight Molecular Diagnostics (IMDX) Tax Provisions (2020 - 2021) Analysis & Trends

Insight Molecular Diagnostics has reported Tax Provisions for 2 years, with the latest figure at -$97000.0 in Q4 2021.

  • Quarterly Tax Provisions fell 161.01% year-over-year to -$97000.0 in Q4 2021, while the trailing twelve-month figure through Sep 2024 was -$97000.0 (changed N/A YoY) and the FY2022 annual result came in at -$1.2 million, up 87.04% from the prior year.
  • Tax Provisions grew to -$97000.0 in Q4 2021 per IMDX's latest filing, from -$1.8 million in the prior quarter.
  • Over five years, Tax Provisions peaked at $1.1 million in Q1 2020 and troughed at -$7.6 million in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Thermo Fisher Scientific 213.88 Bn 209.81 Bn 8.34 Bn 167.00 Mn
2 Danaher 140.65 Bn 136.30 Bn 3.61 Bn 208.00 Mn
3 Idexx Laboratories 46.02 Bn 45.83 Bn 779.09 Mn 78.81 Mn
4 Agilent Technologies 39.85 Bn 38.05 Bn 990.00 Mn 69.00 Mn
5 Iqvia Holdings 39.20 Bn 37.12 Bn 1.44 Bn 60.00 Mn
6 Natera 38.80 Bn 37.70 Bn 696.04 Mn 300,000.00
7 Illumina 30.11 Bn 28.94 Bn 770.00 Mn 53.00 Mn
8 Mettler Toledo International 28.66 Bn 28.61 Bn 650.22 Mn 56.50 Mn
9 Quest Diagnostics 26.24 Bn 25.61 Bn 1.03 Bn 88.00 Mn
10 Insight Molecular Diagnostics 172.42 Mn 143.49 Mn 15,000.00 -

Historic Data

Download Data
DateValue
Dec 31, 2021 -97,000.00
Jun 30, 2021 -1.79 Mn
Mar 31, 2021 -7.56 Mn
Dec 31, 2020 159,000.00
Jun 30, 2020 -2.19 Mn
Mar 31, 2020 1.10 Mn